18.8671  0.267 (1.44%)		05-22 15:42
Open: 18.72 High: 19.09 Volume: 131,139		Pre. Close: 18.6 Low: 18.26 Market Cap: 334(M)

Short term
Mid term
Targets	6-month :	24.34	1-year :	28.43
Resists	First :	20.84	Second :	24.34
Pivot price	16.41
Supports	First :	14.01	Second :	9.8
MAs	MA(5) :	19.22	MA(20) :	15.13
	MA(100) :	12.33	MA(250) :	21.38
MACD	MACD :	2.2	Signal :	1.8
%K %D	K(14,3) :	81.8	D(3) :	85.5
RSI	RSI(14): 71
52-week	High :	72.59	Low :	0.77

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ OM ] has closed below upper band by 29.4%. Bollinger Bands are 81% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	19.52 - 19.65	19.65 - 19.73
Low:	17.85 - 18	18 - 18.1
Close:	18.41 - 18.62	18.62 - 18.77

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Thu, 22 May 2025
Outset Medical’s SWOT analysis: stock outlook amid commercial transformation - Investing.com Australia

Wed, 21 May 2025
OM: Analyst Shagun Singh Raises Price Target for Outset Medical | OM Stock News - GuruFocus

Wed, 21 May 2025
Outset Medical shares rise on RBC price target boost - Investing.com

Wed, 21 May 2025
Outset Medical Inc. (OM) PT Raised to $21 at RBC Capital - StreetInsider

Wed, 21 May 2025
RBC Raises Price Target on Outset Medical to $21 From $14, Keeps Sector Perform Rating - marketscreener.com

Tue, 20 May 2025
RBC Capital Raises Price Target for Outset Medical (OM) to $21 | OM Stock News - GuruFocus

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	18 (M)
Shares Float	3 (M)
Held by Insiders	0.8 (%)
Held by Institutions	24.7 (%)
Shares Short	1,020 (K)
Shares Short P.Month	788 (K)

EPS	-36.91
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	7.59
Profit Margin	-112.6 %
Operating Margin	-55.4 %
Return on Assets (ttm)	-22.9 %
Return on Equity (ttm)	-171 %
Qtrly Rev. Growth	-3.5 %
Gross Profit (p.s.)	2.2
Sales Per Share	6.41
EBITDA (p.s.)	-5.77
Qtrly Earnings Growth	0 %
Operating Cash Flow	-116 (M)
Levered Free Cash Flow	-70 (M)

PE Ratio	-0.52
PEG Ratio	0
Price to Book value	2.49
Price to Sales	2.95
Price to Cash Flow	-2.89

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.